ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $7,000 | -99.8% | 3,084 | +102.8% | 0.00% | – |
| Q2 2018 | $3,514,000 | +58466.7% | 1,521 | -16.2% | 0.00% | -100.0% |
| Q1 2018 | $6,000 | +50.0% | 1,816 | +65.7% | 0.00% | – |
| Q4 2017 | $4,000 | -33.3% | 1,096 | -18.6% | 0.00% | -100.0% |
| Q3 2017 | $6,000 | +100.0% | 1,346 | +68.5% | 0.00% | – |
| Q2 2017 | $3,000 | -81.2% | 799 | -53.4% | 0.00% | -100.0% |
| Q1 2017 | $16,000 | -30.4% | 1,716 | -42.3% | 0.00% | -50.0% |
| Q4 2016 | $23,000 | – | 2,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|